Halo Neuroscience CEO talks about its dual approach to the neurostimulation market
Daniel Chao, who previously co-founded NeuroPace, said unlike most startups, the company didn't have a specific product in mind when it launched in 2013.
Halo Neuroscience raises $9M Series A for neurostimulation for athletics, stroke rehab
Lux Capital led the round with participation from Andreessen Horowitz, Jazz Venture Partners, SoftTech Ventures and Xfund.
The New Blueprint: How Clever Care Health Plan is Scaling Its Member Experience [Video]
MedCity News was at the Vive conference and spoke with executives who shared their insights for the healthcare industry.